Ray Dalio Sarepta Therapeutics, Inc. Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 23,222 shares of SRPT stock, worth $3.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,222

Previous 26,388 12.0%

Holding current value

$3.02 Million

Previous $2.54 Million 18.16%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $296,654 - $448,083	-3,166 Reduced 12.0%	23,222 $3.01 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1.62 Million - $3 Million	-24,076 Reduced 47.71%	26,388 $2.54 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $2.01 Million - $2.42 Million	19,608 Added 63.55%	50,464 $6.12 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $41,070 - $60,675	386 Added 1.27%	30,856 $3.53 Million
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $3.23 Million - $4.28 Million	-27,465 Reduced 47.41%	30,470 $4.2 Million

Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $4.08 Million - $5.35 Million	-40,473 Reduced 41.13%	57,935 $7.51 Million
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $2.05 Million - $3.23 Million	-27,110 Reduced 21.6%	98,408 $10.9 Million
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $7.59 Million - $10.7 Million	121,144 Added 2769.64%	125,518 $9.41 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $276,218 - $395,497	4,374 New	4,374 $342,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $253,192 - $354,938	-3,838 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $25,670 - $32,097	-370 Reduced 8.79%	3,838 $298,000
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $304,028 - $710,941	4,208 New	4,208 $314,000

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account